Published by Josh White on 14th May 2021
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has signed a sublicence agreement for the rights to United States patent US9,376,478, it announced on Friday, which currently extends to 2033.
URL: http://www.digitallook.com/dl/news/story/31848448/...